The overexpression of eukaryotic translation initiation factor 4E (eIF4E)-binding protein 1 (4EBP1) in NSCLC patients has been related to a lower survival (Tang et al., 2022). The gene discussed is EIF4EBP1; the disease is non-small cell lung carcinoma.